ZHEJIANG MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.53 CNY | +0.42% |
|
+2.47% | -11.18% |
| Apr. 25 | Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 2023 | Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug | MT |
Evolution of the average Target Price on Zhejiang Medicine Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
37763fa72846fa16d2.EdmQLhAKHV0l2f8QiCP3sgX3oABls0HbTCuhjQZGFd8.a6ypfFF4RzN6vq9q33Ou0z2fx3lI-yi2fWTR20QAZOsgttF7fWctORGztg~71461a23ed09e1a5e7473c3f2716c94e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.53
CNY
Average target price
11
CNY
Spread / Average Target
+15.42%
High Price Target
11
CNY
Spread / Highest target
+15.42%
Low Price Target
11
CNY
Spread / Lowest Target
+15.42%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600216 Stock
- Consensus Zhejiang Medicine Co., Ltd.
